An international team of researchers has developed a method that combines advanced high-throughput microfluidics and gene editing technology to source new treatments that could potentially help people with autoimmune conditions and cancer. In validating the new technique, they discovered a molecule they believe could inhibit interferon gamma production in the gut which — if proven in clinical trials — could represent an ideal means to control inflammatory bowel disease (IBD…
Read More
About The Author
